Atrial Fibrillation in Heart Failure Focus on Antithrombotic Management

被引：1
作者：
Obeidat, Mohammed [1 ]
Burgess, Malcolm [1 ]
Lip, Gregory Y. H. [2 ,3 ,4 ,5 ]
机构：
[1] Aintree Hosp, Dept Cardiol, Liverpool, England
[2] Univ Liverpool Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[3] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
[4] Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg 6 West Derby St, Liverpool L7 8TX, England
[5] Chest Hosp, Liverpool, Merseyside, England
来源：
CARDIOLOGY CLINICS | 2022年 / 40卷 / 02期
关键词：
Atrial fibrillation; Heart failure; Anticoagulation; NOAC; Direct oral anticoagulant; PRESERVED EJECTION FRACTION; 2016 ESC GUIDELINES; ORAL ANTICOAGULANTS; PROGNOSTIC-SIGNIFICANCE; STROKE PREVENTION; CARDIAC STRUCTURE; ADVERSE OUTCOMES; NERVOUS-SYSTEM; WARFARIN; RISK;
D O I：
10.1016/j.ccl.2021.12.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：245 / 258
页数：14
相关论文
共 75 条
  • [1] Prediction of embolism in atrial fibrillation - Classification of left atrial thrombi by transesophageal echocardiography
    Abe, Y
    Asakura, T
    Gotou, J
    Iwai, M
    Watanabe, Y
    Sando, M
    Ishikawa, S
    Nagata, K
    Saito, T
    Maehara, K
    Maruyama, Y
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2000, 64 (06): : 411 - 415
  • [2] Ahmad Y, 2012, EXPERT REV CARDIOVAS, V10, P1471, DOI [10.1586/ERC.12.148, 10.1586/erc.12.148]
  • [3] [Anonymous], OVERVIEW J ATRIAL FI
  • [4] Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic
    Anter, Elad
    Jessup, Mariell
    Callans, David J.
    [J]. CIRCULATION, 2009, 119 (18) : 2516 - 2525
  • [5] Pathophysiologic Mechanisms in Heart Failure: Role of the Sympathetic Nervous System
    Antoine, Steve
    Vaidya, Gaurang
    Imam, Haider
    Villarreal, Daniel
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (01) : 27 - 30
  • [6] Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial
    Apostolakis, Stavros
    Lane, Deirdre A.
    Buller, Harry
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 110 (05) : 1074 - 1079
  • [7] Atrial fibrillation in heart failure: the chicken or the egg?
    Balasubramaniam, R.
    Kistler, P. M.
    [J]. HEART, 2009, 95 (07) : 535 - 539
  • [8] Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study
    Balsam, Pawel
    Gawalko, Monika
    Peller, Michal
    Tyminska, Agata
    Ozieranski, Krzysztof
    Zaleska, Martyna
    Zukowska, Katarzyna
    Szepietowska, Katarzyna
    Maciejewski, Kacper
    Grabowski, Marcin
    Borkowski, Mariusz
    Koltowski, Lukasz
    Praska-Oginska, Anna
    Zaboyska, Inna
    Opolski, Grzegorz
    Bednarski, Janusz
    [J]. MEDICINE, 2018, 97 (45)
  • [9] Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights
    Borer, Jeffrey S.
    Atar, Dan
    Marciniak, Thomas
    Kim, Moo Hyun
    Serebruany, Victor
    [J]. THROMBOSIS AND HAEMOSTASIS, 2019, 119 (03) : 355 - 357
  • [10] Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review
    Borre, Ethan D.
    Goode, Adam
    Raitz, Giselle
    Shah, Bimal
    Lowenstern, Angela
    Chatterjee, Ranee
    Sharan, Lauren
    LaPointe, Nancy M. Allen
    Yapa, Roshini
    Davis, J. Kelly
    Lallinger, Kathryn
    Schmidt, Robyn
    Kosinski, Andrzej
    Al-Khatib, Sana M.
    Sanders, Gillian D.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2018, 118 (12) : 2171 - 2187
12345678